Company Filing History:
Years Active: 2010-2016
Title: The Innovative Contributions of Inventor Christiane Hollmann
Introduction
Christiane Hollmann, an accomplished inventor based in Wedemark, Germany, has made significant strides in the field of biomedical innovations. With a total of four patents to her name, her research focuses particularly on the development of monoclonal antibodies, which are crucial for medical diagnostics and treatments.
Latest Patents
Among her latest patents is a groundbreaking development of monoclonal antibodies with specificity for fetal erythroid cells. This invention concerns a monoclonal antibody and corresponding hybridoma cells and antigens that are suitable for isolating fetal cells from maternal blood. The inventive monoclonal antibody reacts with a surface antigen present on fetal red blood cells, including their nucleated precursor cells, while showing specificity by not interacting with surface antigens found on adult erythroid cells. This innovative approach could pave the way for advancements in prenatal diagnostics and non-invasive testing methods.
Career Highlights
Christiane has contributed her expertise to notable companies such as Kellbenx Inc. and Adnagen AG. Her work in these organizations reflects her commitment to advancing medical technology. Through her innovative thinking and dedication, she has positioned herself as a key figure in biotechnology.
Collaborations
Throughout her career, Christiane has collaborated with esteemed colleagues, including Silke Zimmermann and Stefan Stachelhaus. These partnerships have fostered an environment of joint innovation, leading to significant advancements in their respective fields.
Conclusion
In conclusion, Christiane Hollmann exemplifies the spirit of innovation within the biotechnology sector. Her four patents, particularly those related to monoclonal antibodies, not only demonstrate her inventive prowess but also hold the potential to influence future medical practices. As her career progresses, her contributions will undoubtedly continue to impact the field significantly.